Table 1.
Percentage compliance with individual STARD criteria for included diagnostic accuracy studies in gynaecology
| STARD Item | Description | Percentage compliance overall gynaecology (%) N = 105 |
Percentage compliance pre 2004 (%) N = 85 |
Percentage compliance post 2004 (%) N = 17 |
Difference % (95% CI) |
|---|---|---|---|---|---|
| S1 | Article is identified as study of diagnostic accuracy | 64.8% | 64.8% | 64.7% | -0.1% (-25%; 25%) |
| S2 | States research question or aims | 63.6% | 63.6% | 64.7% | 1.1% (-24%; 26%) |
| S3 | Describes study population | 77.3% | 77.3% | 64.7% | -12.6% (-35%; 10%) |
| S4 | Describes participant recruitment | 35.2% | 35.2% | 94.1% | 58.9% (33%; 85%) |
| S5 | Describes participant sampling | 40.9% | 40.9% | 64.7% | 23.8% (-2%; 50%) |
| S6 | Describes index standard | 83.0% | 83.0% | 88.2% | 5.3% (-14%; 24%) |
| S7 | Describes reference standard | 30.7% | 30.7% | 76.5% | 45.8% (21%; 71%) |
| S8a | Describes technique of index test | 50.0% | 50.0% | 82.4% | 32.4% (7%; 58%) |
| S8b | Describes technique of reference standard | 30.7% | 30.7% | 70.6% | 39.9% (15%; 65%) |
| S9a | Describes cut-off for index test | 96.6% | 96.6% | 70.6% | -26.0% (-40%; -12%) |
| S9b | Describes cut-off for reference standard | 0.0% | 0.0% | 0.0% | 0.0% (0%; 0%) |
| S10a | Describes persons executing index test | 3.4% | 3.4% | 5.9% | 2.5% (-7%; 12%) |
| S10b | Describes persons executing reference standard | 0.0% | 0.0% | 0.0% | 0% |
| S11a | Were results of index test blinded? | 22.7% | 22.7% | 0.0% | -22.7% (-43%; -2%) |
| S11b | Were results of reference test blinded? | 20.5% | 20.5% | 11.8% | -8.7% (-29%; 12%) |
| S12 | Describes methods for statistics used | 30.7% | 30.7% | 0.0% | -30.7% (-53%; -8%) |
| S13 | Describes methods for calculating test reproducibility | 0.0% | 0.0% | 0.0% | 0% |
| S14 | Reports dates of study | 86.4% | 86.4% | 94.1% | 7.8% (-9%; 25%) |
| S15 | Reports characteristics of study population | 10.2% | 10.2% | 11.8% | 1.5% (-14%; 17%) |
| S16 | Reports number of eligible patients that did not undergo either test | 34.1% | 34.1% | 41.2% | 7.1% (-18%; 32%) |
| S17 | Time interval between tests and any treatment | 70.5% | 70.5% | 94.1% | 23.7% (1%; 46%) |
| S18 | Reports distribution of severity of disease | 75.0% | 75.0% | 94.1% | 19.1% (-2%; 41%) |
| S19 | Reports cross tabulation of results | 42.0% | 42.0% | 29.4% | -12.6% (-38%; 13%) |
| S20 | Reports adverse events | 15.9% | 15.9% | 17.6% | 1.7% (-17%; 21%) |
| S21 | Reports estimates of diagnostic accuracy | 62.5% | 62.5% | 41.2% | -21.3% (-47%; 4%) |
| S22 | Reports how missing results were handled | 21.6% | 21.6% | 35.3% | 13.7% (-8%; 36%) |
| S23 | Reports estimates of variability of accuracy | 0.0% | 0.0% | 0.0% | 0% |
| S24 | Reports estimates of test reproducibility | 0.0% | 0.0% | 0.0% | 0% |
| S25 | Discuss clinical applicability of findings | 100.0% | 100.0% | 100.0% | 0% |
* 100% not applicable